Avalo Therapeutics (AVTX) has issued an announcement.
Avalo Therapeutics, Inc. has appointed the seasoned legal professional Paul Varki as their new Chief Legal Officer. With a rich background in the pharmaceutical industry, Varki’s over two decades of experience includes roles at Idorsia Pharmaceuticals and Amarin Corporation. The company has structured a competitive compensation package for Varki, including a base salary, potential bonuses, stock options, and severance benefits, underscoring their commitment to securing top legal expertise to navigate the complex pharmaceutical landscape.
See more insights into AVTX stock on TipRanks’ Stock Analysis page.
